Association Between C-Reactive Protein–Triglyceride–Glucose Index and Adverse Prognosis Outcomes in Patients with Acute Myocardial Infarction
Open Access
- 1 July 2026
- journal article
- research article
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 13 (7) , 298
Abstract
Background: The C-reactive protein–triglyceride–glucose index (CTI) integrates inflammation and insulin resistance, but its association with adverse outcomes in acute myocardial infarction (AMI) patients remains unclear. This study aimed to investigate the association between CTI and adverse outcomes, including major adverse cardiac events (MACEs), all-cause death, cardiac death, and myocardial infarction in AMI patients. Methods: The CTI of patients with acute myocardial infarction was calculated and divided into three groups according to its tertiles. Multivariable Cox regression, restricted cubic spline analysis, survival analysis, and correlation heat map analysis were used to explore the association between the CTI and adverse outcomes such as major adverse cardiac events (MACEs), cardiac death, all-cause death and myocardial infarction in patients with acute myocardial infarction. Results: A total of 965 patients were enrolled in this study. In the adjusted Model 3, CTI remained significantly associated with myocardial infarction (Q3 vs. Q1: HR = 2.40, 95% CI: 1.37–4.17, p = 0.001; p for trend = 0.001). However, the associations with MACEs (HR = 1.29, p = 0.161), all-cause death (HR = 1.28, p = 0.337), and cardiac death (HR = 1.78, p = 0.221) were not statistically significant after full adjustment. Restricted cubic spline analysis identified a threshold effect for myocardial infarction at CTI > 5.92, above which the risk increased 5.61-fold (HR = 5.61, 95% CI: 2.94–10.71, p < 0.001). The Kaplan–Meier survival curve showed that the higher the CTI tertiles, the higher the incidence of adverse outcomes. Conclusions: Elevated CTI levels were independently associated with an increased risk of myocardial infarction in AMI patients.Keywords
Funding Information
- Sci-Tech Supporting Program of Jiangsu Commission of Health (M2021019)
- Medical Sci-Tech innovation Program for Medical Care of Suzhou City (SKY2021005)
This publication has 23 references indexed in Scilit:
- Association of the C-reactive protein-triglyceride glucose index with new-onset myocardial infarction risk: a prospective cohort studyScientific Reports, 2026
- Associations between insulin resistance indices and subclinical atherosclerosis: A contemporary reviewAmerican Journal of Preventive Cardiology, 2024
- Value of C-Reactive Protein-Triglyceride Glucose Index in Predicting Cancer Mortality in the General Population: Results from National Health and Nutrition Examination SurveyNutrition and Cancer, 2023
- Association between obesity, inflammation and insulin resistance: Insights into signaling pathways and therapeutic interventionsDiabetes Research and Clinical Practice, 2023
- Improved long-term survival after acute myocardial infarction: the success of comprehensive care from the acute stage to the long termEuropean Heart Journal, 2022
- Metabolic syndrome and cardiovascular diseases: Going beyond traditional risk factorsDiabetes/Metabolism Research and Reviews, 2021
- Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunitiesNature Reviews Cardiology, 2019
- Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventionsAtherosclerosis, 2018
- 2018 ESC/ESH Guidelines for the management of arterial hypertensionEuropean Heart Journal, 2018
- Third universal definition of myocardial infarctionNature Reviews Cardiology, 2012